Combined Mitral and Tricuspid Transcatheter Edge-to-Edge Repair: Evidence, Patient Selection, and Procedural Strategy
Year: 2026
Type: article
Abstract: Concomitant mitral regurgitation (MR) and tricuspid regurgitation (TR) constitute an interconnected multivalvular syndrome, but correction of MR does not consistently reverse TR. This narrative review examines TR evolution after mitral transcatheter edge-to-edge repair (M-TEER), patient selection, imaging, procedural strategies, and evidence for treatment of both valves. Combined TEER denotes bivalvular treatment, performed during the same session or in stages. Observational cohorts report TR improvement in approximately one-third of broadly selected patients after M-TEER, with substantial variation according to baseline severity, response definition, and follow-up. Persistent or new-onset TR is associated with adverse outcomes; these associations do not establish that subsequent tricuspid intervention improves survival. Comparative registries suggest potential clinical benefit from combined treatment, whereas uncontrolled series primarily establish technical feasibility in selected patients at experienced centers. Treatment timing remains uncertain because randomized comparisons of isolated, same-session, and staged strategies are unavailable. The proposed Heart Team framework integrates lesion-specific indications, anatomical suitability, anticipated TR reversibility, physiological reserve, and patient goals. It is an unvalidated discussion aid rather than a treatment recommendation. Randomized strategy trials are needed to establish incremental clinical benefit, comparative safety, and optimal timing.
Source: Medicina
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,654
OpenAlex ID: W7236603594
